Jabra is launching a 501(k) cleared (FDA) self fitting hearing aid at the end of February 2022.
If you’re not familiar with hearing aid pricing (in the US,) you might want to know that at least on the upper end in the US hearing aids could top out at $6000. The target of Jabra’s aims (left and right, mild to moderate loss,) appears to be in the $800-$1700 price range per ear if I’m seeing this correctly.
Jabra’s offering (The Jabra Enhance Plus,) will come in at an MSRP of $799 for both ears, be self fitting, and available over the counter.
Besides amplifications, they claim to have audio processing that reduces noise and improves speech clarity. They will also be able to stream music, make phone calls, and do all the things earbuds do.
My guess is they’ll also be able to be configured to your liking via a Jabra app.
501(k) FDA cleared means it demonstrates that the device to be marketed is safe and effective and is equivalent to a legally marketed device. So these should be as good as something in the market currently.[Jabra press release]